Comparison of Radiofrequency Ablation and Transarterial Chemoembolization in Advanced Liver Cancer Survival Rates
DESCRIPTION
This study compares survival rates in patients with advanced liver cancer treated with Radiofrequency Ablation (RFA) and Transarterial Chemoembolization (TACE) at different stages. Results show significant differences in survival rates between RFA and TACE treatments.
1 / 1
Télécharger la présentation
Comparison of Radiofrequency Ablation and Transarterial Chemoembolization in Advanced Liver Cancer Survival Rates
An Image/Link below is provided (as is) to download presentation
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.
Content is provided to you AS IS for your information and personal use only.
Download presentation by click this link.
While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
During download, if you can't get a presentation, the file might be deleted by the publisher.
E N D
Presentation Transcript
JIS 3 Child-Pugh A / stage IVA JIS 3 Child-Pugh B / stage III A B RFA (n=3) 100 100 RFA (n=20) 80 80 68% HR vs. RFA: P=0.68 HR vs. TACE: P<0.01 RFA vs. TACE: P=0.27 66% 60 60 Patient’s survival (%) Patient’s survival (%) HR (n=59) 40 40 26% HR (n=298) HR vs. RFA: P=0.77 HR vs. TACE: P<0.01 RFA vs. TACE: P<0.01 TACE (n=131) 20 20 TACE (n=53) 0 0 2 4 2 4 0 1 3 5 0 1 3 5 Years after treatment Years after treatment
More Related